济川药业 (600566.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

10.6x

EV/EBITDA

8.3x

Market Cap

CNY 22.48B

MomentumView details →

1D Return

+0.04%

YTD Return

−2.13%

RSI (14)

53.4

ValuationView details →

P/E (Fwd)

10.6x

EV/EBITDA

8.3x

Market Cap

CNY 22.48B

RSI (14)

53.4

MomentumView details →

1D Return

+0.04%

YTD Return

−2.13%

ProfitabilityView details →

Gross Margin

80.04%

Net Margin

29.45%

EBITDA Margin

41.83%

ROE (TTM)

11.59%

ROA (TTM)

9.74%

Asset Turnover

0.33x

GrowthView details →

Revenue YoY

−17.35%

EPS YoY

−18.34%

FCF YoY

−32.76%

Revenue CAGR 3Y

−11.58%

EPS CAGR 3Y

−7.52%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.41

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.47

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.05x

Current Ratio

5.46x

Quick Ratio

5.32x

Div Yield

6.76%

Div Rate

CNY 1.74

Div Growth 1Y

−16.75%

Financials snapshotView financials →

Revenue (TTM)

5.90B

Net Income (TTM)

1.74B

Op. CF (TTM)

1.28B

Next earningsOct 26, 2026 →

Latest newsMore news →

Jichuan Pharmaceutical's employee representative director Huang Qurong reduced his shareholding by 96,000 shares on August 31, 2026, completing his reduction plan.3d ago

Similar companies

天士力600535.SH Aprogen Biologics Inc.003060.KS Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited00874.HK 华海药业600521.SH 哈药股份600664.SH The United Laboratories International Holdings Limited03933.HK Find similar companies →

Latest newsMore news →

Jichuan Pharmaceutical's employee representative director Huang Qurong reduced his shareholding by 96,000 shares on August 31, 2026, completing his reduction plan.3d ago